Unknown

Dataset Information

0

Characterization of the alpha1-adrenoceptor subtype mediating contractions of the pig internal anal sphincter.


ABSTRACT: BACKGROUND AND PURPOSE: The internal anal sphincter has been shown to contract in response to alpha1-adrenoceptor stimulation and therefore alpha1-adrenoceptor agonists may be useful in treating faecal incontinence. This study characterizes the alpha1-adrenoceptor subtype responsible for mediating contraction of the internal anal sphincter of the pig. EXPERIMENTAL APPROACH: The potency of agonists and the affinities of several receptor subtype selective antagonists were determined on smooth muscle strips for the pig internal anal sphincter. Cumulative concentration-response curves were performed using phenylephrine and noradrenaline. KEY RESULTS: The potency of the alpha1A-adrenoceptor selective agonist A61603 (pEC50=7.79+/-0.04) was 158-fold greater than that for noradrenaline (pEC50=5.59+/-0.02). Phenylephrine (pEC50=5.99+/-0.05) was 2.5-fold more potent than noradrenaline. The alpha1D-adrenoceptor selective antagonist BMY7378 caused rightward shifts of the concentration-response curves to phenylephrine and noradrenaline, yielding low affinity estimates of 6.59+/-0.15 and 6.33+/-0.13, respectively. Relatively high affinity estimates were obtained for the alpha1A-adrenoceptor selective antagonists, RS100329 (9.01+/-0.14 and 9.06+/-0.22 with phenylephrine and noradrenaline, respectively) and 5-methylurapidil (8.51+/-0.10 and 8.31+/-0.10, respectively). Prazosin antagonized responses of the sphincter to phenylephrine and noradrenaline, yielding mean affinity estimates of 8.58+/-0.10 and 8.15+/-0.08, respectively. The Schild slope for prazosin with phenylephrine was equal to unity (1.01+/-0.24), however the Schild slope using noradrenaline was significantly less than unity (0.50+/-0.11, P<0.05). CONCLUSION AND IMPLICATIONS: The results suggest that contraction of circular smooth muscle from the pig internal anal sphincter is mediated via a population of adrenoceptors with the pharmacological characteristics of the alpha1A/L-adrenoceptor, most probably the alpha1L-adrenoceptor form of this receptor.

SUBMITTER: Mills K 

PROVIDER: S-EPMC2527848 | biostudies-other | 2008 Sep

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC2949785 | biostudies-literature
| S-EPMC3245326 | biostudies-literature
| S-EPMC2643912 | biostudies-literature
| S-EPMC4844698 | biostudies-other
| S-EPMC5130548 | biostudies-literature
| S-EPMC4254957 | biostudies-literature
| S-EPMC4451323 | biostudies-literature
| S-EPMC5431208 | biostudies-literature
| S-EPMC3192126 | biostudies-literature
| S-EPMC4575824 | biostudies-literature